News

CRN04894, a first-in-class, experimental oral medication for Cushing’s disease, led to a dose-dependent drop in blood and urine cortisol levels in healthy volunteers, top-line data from a Phase 1 trial showed. According to Crinetics Pharmaceuticals, the therapy’s developer, patient studies are expected to launch later this year. In…

The case of a woman with a rare form of Cushing’s syndrome whose main symptom was blurry vision was described in a recent report. The report, “Intermittent Blurry Vision: An Unexpected Presentation of Cushing’s Syndrome Due to Primary Bilateral Macronodular Adrenal Hyperplasia (PBMAH),” was published in…

Nearly 1.5 years of treatment with Isturisa (osilodrostat) rapidly and sustainably eased — and in many cases completely eliminated — disease-associated physical features in people with Cushing’s disease, according to data from the Phase 3 LINC 3 trial. Improvements were noted from early on, consistent with the…

Continuous treatment with Recorlev (levoketoconazole) helped to lower blood cholesterol levels in adults with endogenous Cushing’s syndrome, according to data from the Phase 3 LOGICS trial. Scientists at Xeris Biopharma, the company that markets Recorlev, presented the findings in the poster “Levoketoconazole in the Treatment of Endogenous…

Pituitary tumors producing excessive amounts of adrenocorticotropic hormone (ACTH) — the most common cause of Cushing’s disease — carry more genetic abnormalities than those not generating excess ACTH levels, also called non-functioning tumors, a small study shows. The data also identified two genes that may be involved in the…

High levels of the hormone precursor copeptin following surgery might be associated with remission in people with Cushing’s disease who do not later develop water balance disorders, new data indicate. However, the scientists stressed the need for further research on this potential biomarker, noting that copeptin levels after surgery…

People with Cushing’s syndrome, a group of conditions that includes Cushing’s disease, have a three-times-higher risk of mortality compared with the general population, according to a pooled analysis of multiple studies. Preventing and managing co-existing conditions, especially cardiovascular disease, in addition to treating Cushing’s, may benefit at least half…

A Russian military plane crash near Tetiana Zamorska’s home in Kyiv, Ukraine, was a sign that it was time for her and her family to leave. The treacherous, 34-hour pilgrimage that ultimately brought the group of eight by car to temporary accommodations in neighboring Poland last month was physically and emotionally difficult,…

The size of pituitary tumors that cause Cushing’s disease do not affect the levels of cortisol or clinical features in patients, a study suggests. The tumor’s ability to invade other brain tissues, however, likely impacts the chances of tumor removal and disease remission, researchers noted. The study, “Clinical…

Undergoing a surgical removal of the adrenal glands — called adrenalectomy — was associated with a better prognosis than cortisol-suppressing therapies alone in people with ectopic Cushing’s syndrome (ECS) caused by a neuroendocrine tumor (NET), according to a recent report. Patients who received an ectopic Cushing’s diagnosis after being found…